ATE327250T1 - Kristallstruktur von ribosomen und proteinsynthese-inhibitoren - Google Patents

Kristallstruktur von ribosomen und proteinsynthese-inhibitoren

Info

Publication number
ATE327250T1
ATE327250T1 AT01306825T AT01306825T ATE327250T1 AT E327250 T1 ATE327250 T1 AT E327250T1 AT 01306825 T AT01306825 T AT 01306825T AT 01306825 T AT01306825 T AT 01306825T AT E327250 T1 ATE327250 T1 AT E327250T1
Authority
AT
Austria
Prior art keywords
methods
protein synthesis
synthesis inhibitors
ligands
ribosomes
Prior art date
Application number
AT01306825T
Other languages
English (en)
Inventor
Thomas A Steitz
Peter B Moore
Nenad Ban
Poul Nissen
Jeffrey Hansen
Original Assignee
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/635,708 external-priority patent/US6638908B1/en
Application filed by Univ Yale filed Critical Univ Yale
Application granted granted Critical
Publication of ATE327250T1 publication Critical patent/ATE327250T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5355—Non-condensed oxazines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/215—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Halobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
  • Enzymes And Modification Thereof (AREA)
AT01306825T 2000-08-09 2001-08-09 Kristallstruktur von ribosomen und proteinsynthese-inhibitoren ATE327250T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US22397700P 2000-08-09 2000-08-09
US09/635,708 US6638908B1 (en) 2000-08-09 2000-08-09 Crystals of the large ribosomal subunit
US30699601P 2001-07-20 2001-07-20
US30928101P 2001-08-01 2001-08-01
US09/922,251 US6947844B2 (en) 2000-08-09 2001-08-03 Modulators of ribosomal function and identification thereof

Publications (1)

Publication Number Publication Date
ATE327250T1 true ATE327250T1 (de) 2006-06-15

Family

ID=27539870

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01306825T ATE327250T1 (de) 2000-08-09 2001-08-09 Kristallstruktur von ribosomen und proteinsynthese-inhibitoren

Country Status (8)

Country Link
US (3) US6947844B2 (de)
EP (1) EP1188769B1 (de)
JP (1) JP3836702B2 (de)
AT (1) ATE327250T1 (de)
AU (1) AU768033B2 (de)
CA (1) CA2354051A1 (de)
DE (2) DE60119853T2 (de)
IL (1) IL144830A0 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638908B1 (en) * 2000-08-09 2003-10-28 Yale University Crystals of the large ribosomal subunit
US6947844B2 (en) * 2000-08-09 2005-09-20 Yale University Modulators of ribosomal function and identification thereof
WO2002046392A2 (en) * 2000-12-09 2002-06-13 The Regents Of The University Of California X ray crystal structures at 5.5 a resolution of functional complexes of the bacterial ribosome containing transfer rna and model messenger rnas
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
US7067148B2 (en) 2001-02-15 2006-06-27 King Pharmaceutical Research & Development, Inc. Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
US6952650B2 (en) 2001-08-03 2005-10-04 Yale University Modulators of ribosomal function and identification thereof
EP1308457B1 (de) * 2001-08-03 2013-12-04 Yale University Struktur von ribosomen und proteinsynthese-inhibitoren
IL151012A0 (en) * 2001-08-03 2003-02-12 Ribosomes Structure And Protei Ribosomes structure and protein synthesis inhibitors
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
WO2004057340A1 (en) 2002-12-23 2004-07-08 Astex Technology Limited Synthesis and screening of ligands using x-ray crystallography
EP1611546B1 (de) * 2003-04-04 2013-01-02 Icosystem Corporation Verfahren und systeme zur interaktiven evolutionären datenverarbeitung (iec)
US8374794B1 (en) 2003-06-02 2013-02-12 Rib-X Pharmaceuticals, Inc. Protein synthesis modulators
US8428884B1 (en) * 2003-07-14 2013-04-23 Rib-X Pharmaceuticals, Inc. Protein synthesis modulators
WO2005013081A2 (en) 2003-08-01 2005-02-10 Icosystem Corporation Methods and systems for applying genetic operators to determine system conditions
US7356518B2 (en) * 2003-08-27 2008-04-08 Icosystem Corporation Methods and systems for multi-participant interactive evolutionary computing
WO2005047520A2 (en) * 2003-11-07 2005-05-26 Dna Software, Inc. System and methods for three dimensional molecular structural analysis
WO2005115454A2 (en) * 2004-05-07 2005-12-08 Massachusetts Institute Of Technology Methods and compositions for cancer treatment relating to brca1 brct domain recognition of phosphorylated bach1
US7707220B2 (en) 2004-07-06 2010-04-27 Icosystem Corporation Methods and apparatus for interactive searching techniques
WO2006121703A2 (en) * 2005-05-06 2006-11-16 The Board Of Trustees Of The University Of Illinois Mapping new sites for antibiotic action in the ribosome
US8423323B2 (en) 2005-09-21 2013-04-16 Icosystem Corporation System and method for aiding product design and quantifying acceptance
US7792816B2 (en) 2007-02-01 2010-09-07 Icosystem Corporation Method and system for fast, generic, online and offline, multi-source text analysis and visualization
MX2015014666A (es) 2013-04-17 2016-03-01 Pfizer Derivados de n-piperidin-3-ilbenzamida para tratar enfermedades cardiovasculares.
CN103217674B (zh) * 2013-04-22 2015-10-14 西北工业大学 一种逆合成孔径雷达的目标三维散射中心重构方法
EP3250585B1 (de) 2015-01-29 2019-08-14 Yeda Research and Development Co., Ltd. Kristallstruktur der grossen ribosomalen untereinheit aus s. aureus
CN115148293B (zh) * 2022-06-01 2025-06-13 浙江迪谱诊断技术有限公司 全长核糖体rna数据库的构建方法、应用、装置及电子设备
JP7261346B1 (ja) * 2022-12-20 2023-04-19 賢三 小俣 アミデーション反応のシミュレーション方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336768A (en) * 1988-05-24 1994-08-09 Hoffmann-La Roche Inc. Antibacterial cephalosporin compounds
US5180719A (en) * 1988-10-24 1993-01-19 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl lactam esters
US5466681A (en) * 1990-02-23 1995-11-14 Microcarb, Inc. Receptor conjugates for targeting penicillin antibiotics to bacteria
US6446032B1 (en) * 1990-09-21 2002-09-03 Massachusetts Institute Of Technology Designing compounds specifically inhibiting ribonucleic acid by binding to the minor groove
ES2101119T3 (es) * 1991-10-01 1997-07-01 Procter & Gamble Pharma Procedimiento para preparar quinolonil-lactamas antimicrobianas.
MY115155A (en) 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
IT1276901B1 (it) 1994-12-13 1997-11-03 Zambon Spa Derivati dell'eritromicina a 9-0-ossina dotati di attivita' antibiotica
US5693791A (en) * 1995-04-11 1997-12-02 Truett; William L. Antibiotics and process for preparation
WO1997035195A1 (en) 1996-03-19 1997-09-25 The Salk Institute For Biological Studies In vitro methods for identifying modulators of members of the steroid/thyroid superfamily of receptors
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
US6437119B1 (en) * 1998-05-07 2002-08-20 William Lawrence Truett Compounds formed from two or three antibiotics and their processes of preparation
WO1999063929A2 (en) 1998-06-08 1999-12-16 Advanced Medicine, Inc. Multibinding inhibitors of microsomal triglyceride transferase protein
IT1301968B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Derivati di eritromicina ad attivita' antibiotica
WO2000032619A1 (en) 1998-11-30 2000-06-08 Ribogene, Inc. Methods and compositions for identification of inhibitors of ribosome assembly
US6380356B1 (en) * 1999-12-07 2002-04-30 Advanced Medicine, Inc. Multivalent polymyxin antibiotics
EP1299109B1 (de) 2000-04-27 2009-07-15 The Scripps Research Institute Bifunktionelle antibiotika
KR20020004089A (ko) 2000-07-01 2002-01-16 오현숙 리보솜 재활용 인자의 삼차원 구조 및 결정화 방법
IL144082A0 (en) 2000-07-14 2002-05-23 Medical Res Council Crystal structure of antibiotics bound to the 30s ribosome and its use
GB0029871D0 (en) * 2000-07-14 2001-01-24 Medical Res Council Crystal structure (V)
US6947844B2 (en) 2000-08-09 2005-09-20 Yale University Modulators of ribosomal function and identification thereof
US6638908B1 (en) * 2000-08-09 2003-10-28 Yale University Crystals of the large ribosomal subunit
WO2002046392A2 (en) 2000-12-09 2002-06-13 The Regents Of The University Of California X ray crystal structures at 5.5 a resolution of functional complexes of the bacterial ribosome containing transfer rna and model messenger rnas
KR20030007161A (ko) * 2001-07-13 2003-01-23 키 스트림 가부시키가이샤 심볼창 타이밍적응제어형 연산회로 및 그것에 사용하는어드레스발생회로
US6952650B2 (en) * 2001-08-03 2005-10-04 Yale University Modulators of ribosomal function and identification thereof
IL151012A0 (en) * 2001-08-03 2003-02-12 Ribosomes Structure And Protei Ribosomes structure and protein synthesis inhibitors
US20030027315A1 (en) 2001-09-24 2003-02-06 Ada Yonath Methods of growing crystals of free and antibiotic complexed large ribosomal subunits, and methods of rationally designing or identifying antibiotics using structure coordinate data derived from such crystals
US20040137518A1 (en) * 2002-01-31 2004-07-15 Lambert Millard Hurst CRYSTALLIZED PPARa LIGAND BINDING DOMAIN POLYPEPTIDE AND SCREENING METHODS EMPLOYING SAME

Also Published As

Publication number Publication date
US6947844B2 (en) 2005-09-20
EP1188769A3 (de) 2002-07-10
IL144830A0 (en) 2002-06-30
DE01306825T1 (de) 2005-03-31
JP2003212896A (ja) 2003-07-30
EP1188769A8 (de) 2003-09-03
DE60119853D1 (de) 2006-06-29
DE60119853T2 (de) 2007-05-10
US20020086308A1 (en) 2002-07-04
JP3836702B2 (ja) 2006-10-25
EP1188769B1 (de) 2006-05-24
US20050234227A1 (en) 2005-10-20
AU5784601A (en) 2002-02-14
AU768033B2 (en) 2003-11-27
US20100131258A1 (en) 2010-05-27
EP1188769A2 (de) 2002-03-20
CA2354051A1 (en) 2002-02-09

Similar Documents

Publication Publication Date Title
ATE327250T1 (de) Kristallstruktur von ribosomen und proteinsynthese-inhibitoren
EA200500169A1 (ru) Замещенные производные 1,3-дифенилпроп-2-ен-1-она, получение и применение
EA200601555A1 (ru) Замещенные индазол-о-глюкозиды
EA200601554A1 (ru) Замещенные индол-о-глюкозиды
EA200601553A1 (ru) Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды
ATE318812T1 (de) Thiazolyl-inhibitoren von tyrosinkinasen der tec- familie
CY1110498T1 (el) Παραγωγα πυραζολης ως αναστολεις των κινασων τυροσινης υποδοχεα
ATE433973T1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
EA200600594A1 (ru) Новые гетероциклические соединения - ингибиторы hsp90 и способы их получения
EA200400006A1 (ru) Бензоилсульфонамиды и сульфонилбензамидины для применения в качестве противоопухолевых агентов
DE60315146D1 (de) Heteroarylsubstituierte biphenylderivate als inhibitoren von p38-kinase
CY1118612T1 (el) Μεθοδοι και χημικες συνθεσεις για την θεραπευτικη αντιμετωπιση των εμμενουσων λοιμωξεων και του καρκινου μεσω αναστολης της οδου προγραμματισμενου κυτταρικου θανατου 1 (pd-1)
DE60236600D1 (de) Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung
BRPI0414599A (pt) pirrol-indóis substituìdos
DE602004024572D1 (de) Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen
ATE484508T1 (de) Furylverbindungen
TW200510403A (en) Cyclic protein tyrosine kinase inhibitors
DE602004017486D1 (de) Substituierte heteroarylbenzofuransäuren
EA200702109A1 (ru) Алкинилпирролопиримидины и их применение в качестве ингибиторов hsp90
DE602004012578D1 (de) Als inhibitoren von c-met geeignete pyrrolzusammensetzungen
ATE534649T1 (de) Imidazothiazole und imidazoxazolderivative als inhibitoren von p38
NO20055741L (no) Nye kjemiske forbindelser
DE602005020062D1 (de) Lyophilisierung von virosomen
DK1606288T3 (da) Benzensulfonamidderivater, fremgangsmåde til fremstilling deraf og deres anvendelse til behandling af smerte
BRPI0615272A2 (pt) inibidores de p38 map kinase e métodos para uso dos mesmos

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties